Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting No phase listed Observational

The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.

ClinicalTrials.gov ID: NCT06324201

Public ClinicalTrials.gov record NCT06324201. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 10:04 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO™ System Use in Conjunction With VISITAG SURPOINT™Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Observational, multi-center, non-randomized, post-market study. This is a nested sub-study of the REAL AF Registry. Consecutive symptomatic drug refractory paroxysmal atrial fibrillation (PAF) patients from the registry will be screened for enrollment, prospectively or retrospectively, to this sub-study per inclusion and exclusion criteria.

Study identification

NCT ID
NCT06324201
Recruitment status
Recruiting
Study type
Observational
Phase
Not listed
Enrollment
250 participants

Conditions and interventions

Interventions

Device

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 26, 2024
Primary completion
Feb 28, 2026
Completion
Feb 29, 2028
Last update posted
Oct 30, 2025

2024 – 2028

United States locations

U.S. sites
21
U.S. states
13
U.S. cities
20
Facility City State ZIP Site status
Arrhythmia Institute at Grandview Birmingham Alabama 35209 Recruiting
Mobile Cardiology Associates Mobile Alabama 36608 Recruiting
Community Memorial Health System Ventura California 93003 Recruiting
Medical City - HCA Aurora Colorado 80012 Recruiting
Naples Community Hospital Naples Florida 34102 Withdrawn
Sarasota Memorial Health Sarasota Florida 34239 Recruiting
Piedmont Healthcare Atlanta Georgia 30309 Recruiting
Norton Heart and Vascular Institute Louisville Kentucky 40205 Recruiting
The Brigham and Womens Hospital Boston Massachusetts 02115 Not yet recruiting
Sparrow Clinical Research Institute Lansing Michigan 48912 Recruiting
Trinity Health-Michigan Heart Ypsilanti Michigan 48197 Recruiting
The Christ Hospital Cincinnati Ohio 45219 Recruiting
University of Cincinnati Cincinnati Ohio 45221 Recruiting
University of Pennsylvania (UPENN) Philadelphia Pennsylvania 19104 Recruiting
Allegheny Health Pittsburgh Pennsylvania 15212 Recruiting
Centra Health, Inc.dba Stroobants Cardiovascular Center Lynchburg Virginia 24501 Recruiting
Bon Secours Medical Group - Richmond Specialty Care Richmond Virginia 23226 Recruiting
Valley Health System Winchester Virginia 22601 Recruiting
Multicare Health Systems-Pulse Heart Puyallup Washington 98372 Recruiting
Franciscan Heart and Vascular Associates Tacoma Washington 98401 Recruiting
Mercy Health Janesville Wisconsin 53548 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06324201, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 30, 2025 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06324201 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →